Hepatology Clinical Development Lead

GSK; Stevenage; Hybrid; GBP 140,000 - 230,000; Full time

Job summary

GSK is seeking a Medical Director in Clinical Development focusing on Hepatology within the Respiratory, Immunology & Inflammation Research Unit. The role entails leading clinical development strategies, designing studies, and driving translational plans for liver disease targets, with cross-functional leadership across disciplines.

Hybrid role based in Stevenage with planned relocation to Cambridge by early 2029.

Qualifications

• Medical Degree required.
• Postgraduate clinical training in Internal Medicine or related.
• Experience in clinical trial conduct, medical monitoring, safety review and data interpretation.
• Strong knowledge of clinical development processes (GCP, ICH) and global regulatory frameworks.
• Cross-functional matrix team experience and collaboration.
• Ability to translate clinical data into meaningful insights for development decisions.

Responsibilities

• Provide clinical development strategy and study/program design across all phases.
• Lead regulatory interactions and prepare briefing documents and responses.
• Provide medical monitoring and safety oversight for study participants.
• Ensure medical governance and scientific integrity across the project.
• Define clinical pillars of translational tables and timelines/endpoints.
• Influence cross-functional teams to advance development plans.

Skills

Clinical Development

Communication

Drug Regulatory Affairs

Evidence Based Decision Making

GCP

Influencing Without Authority

Learning Agility

People Management

Project Management

Scientific Presentations

Strategic Thinking

Education

Medical Degree

Postgraduate clinical training (Internal Medicine/Pathology)

Hepatology fellowship or equivalent

Job description

GSK is seeking a Medical Director in Clinical Development focusing on Hepatology within the Respiratory, Immunology & Inflammation Research Unit. The role entails leading clinical development strategies, designing studies, and driving translational plans for liver disease targets, with cross-functional leadership across disciplines.

Hybrid role based in Stevenage with planned relocation to Cambridge by early 2029.